Retour aux projets

11111.1;6 IEZ169-LS

Eurostars-Projekt Nr. 4792 AntiFlu - Development of novel clinical drug candidates for the treatment of pandemic and seasonal influenza

Résumé

Eurostars-Projekt Nr. 4792 AntiFlu - Development of novel clinical drug candidates for the treatment of pandemic and seasonal influenza

Textes supplémentaires

Abstract

Starting from recently discovered small molecule inhibitors of the influenza virus polymerase, AntiFlu will deliver a new class of antiviral drug candidates. The novel mechanism of action will ensure broad-spectrum efficacy against both human and avian influenza and minimize resistance development.

Participants

Ulrich Kessler

Kontaktperson

ulrich.kessler@pikepharma.com

Pike Pharma GmbH Ulrich Kessler Wagistrasse 27a 8952 Schlieren ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2009-08-31
Date de fin
2013-10-30
Coûts totaux approuvés
CHF 501200.00
Section
15 Bildungsforschung
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%